These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


106 related items for PubMed ID: 1682865

  • 1. Expression of activated rat neu oncogene is sufficient to induce experimental metastasis in 3T3 cells.
    Yu DH, Hung MC.
    Oncogene; 1991 Nov; 6(11):1991-6. PubMed ID: 1682865
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products.
    Yu D, Hamada J, Zhang H, Nicolson GL, Hung MC.
    Oncogene; 1992 Nov; 7(11):2263-70. PubMed ID: 1359495
    [Abstract] [Full Text] [Related]

  • 3. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A.
    Yu D, Wolf JK, Scanlon M, Price JE, Hung MC.
    Cancer Res; 1993 Feb 15; 53(4):891-8. PubMed ID: 8094034
    [Abstract] [Full Text] [Related]

  • 4. Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A.
    Yu D, Shi D, Scanlon M, Hung MC.
    Cancer Res; 1993 Dec 01; 53(23):5784-90. PubMed ID: 7902209
    [Abstract] [Full Text] [Related]

  • 5. Transfected neu oncogene induces human prostate cancer metastasis.
    Zhau HY, Zhou J, Symmans WF, Chen BQ, Chang SM, Sikes RA, Chung LW.
    Prostate; 1996 Feb 01; 28(2):73-83. PubMed ID: 8604395
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Overexpression of the c-erbB-2 gene enhanced intrinsic metastasis potential in human breast cancer cells without increasing their transformation abilities.
    Tan M, Yao J, Yu D.
    Cancer Res; 1997 Mar 15; 57(6):1199-205. PubMed ID: 9067293
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acquisition of a tumorigenic phenotype by a rat ventral prostate epithelial cell line expressing a transfected activated neu oncogene.
    Sikes RA, Chung LW.
    Cancer Res; 1992 Jun 01; 52(11):3174-81. PubMed ID: 1350510
    [Abstract] [Full Text] [Related]

  • 10. Involvement of tyrosine phosphorylation of p185(c-erbB2/neu) in tumorigenicity induced by X-rays and the neu oncogene in human breast epithelial cells.
    Kang KS, Sun W, Nomata K, Morita I, Cruz A, Liu CJ, Trosko JE, Chang CC.
    Mol Carcinog; 1998 Apr 01; 21(4):225-33. PubMed ID: 9585252
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell.
    Muschel RJ, Williams JE, Lowy DR, Liotta LA.
    Am J Pathol; 1985 Oct 01; 121(1):1-8. PubMed ID: 3901774
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Switching off HER-2/neu in a tetracycline-controlled mouse tumor model leads to apoptosis and tumor-size-dependent remission.
    Schiffer IB, Gebhard S, Heimerdinger CK, Heling A, Hast J, Wollscheid U, Seliger B, Tanner B, Gilbert S, Beckers T, Baasner S, Brenner W, Spangenberg C, Prawitt D, Trost T, Schreiber WG, Zabel B, Thelen M, Lehr HA, Oesch F, Hengstler JG.
    Cancer Res; 2003 Nov 01; 63(21):7221-31. PubMed ID: 14612517
    [Abstract] [Full Text] [Related]

  • 15. Rho proteins induce metastatic properties in vivo.
    del Peso L, Hernández-Alcoceba R, Embade N, Carnero A, Esteve P, Paje C, Lacal JC.
    Oncogene; 1997 Dec 18; 15(25):3047-57. PubMed ID: 9444953
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Specific short transmembrane sequences can inhibit transformation by the mutant neu growth factor receptor in vitro and in vivo.
    Lofts FJ, Hurst HC, Sternberg MJ, Gullick WJ.
    Oncogene; 1993 Oct 18; 8(10):2813-20. PubMed ID: 8104327
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of the early genomic growth factor response in neu oncogene-transformed cells.
    Sistonen L, Koskinen PJ, Lehväslaiho H, Lehtola L, Bravo R, Alitalo K.
    Oncogene; 1990 Jun 18; 5(6):815-21. PubMed ID: 1972791
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.